Voyager Therapeutics (VYGR) Competitors $3.68 +0.10 (+2.79%) Closing price 04:00 PM EasternExtended Trading$3.72 +0.04 (+1.09%) As of 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VYGR vs. GYRE, BGM, SANA, NRIX, ABUS, SNDL, OCS, GHRS, TBPH, and PROKShould you be buying Voyager Therapeutics stock or one of its competitors? The main competitors of Voyager Therapeutics include Gyre Therapeutics (GYRE), BGM Group (BGM), Sana Biotechnology (SANA), Nurix Therapeutics (NRIX), Arbutus Biopharma (ABUS), SNDL (SNDL), Oculis (OCS), GH Research (GHRS), Theravance Biopharma (TBPH), and ProKidney (PROK). These companies are all part of the "pharmaceutical products" industry. Voyager Therapeutics vs. Its Competitors Gyre Therapeutics BGM Group Sana Biotechnology Nurix Therapeutics Arbutus Biopharma SNDL Oculis GH Research Theravance Biopharma ProKidney Gyre Therapeutics (NASDAQ:GYRE) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings. Do analysts prefer GYRE or VYGR? Gyre Therapeutics currently has a consensus price target of $18.00, indicating a potential upside of 122.77%. Voyager Therapeutics has a consensus price target of $13.25, indicating a potential upside of 259.98%. Given Voyager Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Voyager Therapeutics is more favorable than Gyre Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gyre Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Voyager Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Which has stronger valuation and earnings, GYRE or VYGR? Gyre Therapeutics has higher revenue and earnings than Voyager Therapeutics. Voyager Therapeutics is trading at a lower price-to-earnings ratio than Gyre Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGyre Therapeutics$102.19M7.62$12.09M$0.01808.00Voyager Therapeutics$42.58M4.79-$65M-$1.85-1.99 Is GYRE or VYGR more profitable? Gyre Therapeutics has a net margin of 4.08% compared to Voyager Therapeutics' net margin of -253.49%. Gyre Therapeutics' return on equity of 7.67% beat Voyager Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Gyre Therapeutics4.08% 7.67% 6.19% Voyager Therapeutics -253.49%-37.65%-28.89% Do institutionals and insiders have more ownership in GYRE or VYGR? 24.0% of Gyre Therapeutics shares are owned by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are owned by institutional investors. 10.0% of Gyre Therapeutics shares are owned by company insiders. Comparatively, 6.4% of Voyager Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media favor GYRE or VYGR? In the previous week, Gyre Therapeutics had 8 more articles in the media than Voyager Therapeutics. MarketBeat recorded 9 mentions for Gyre Therapeutics and 1 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.91 beat Gyre Therapeutics' score of 0.76 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Gyre Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Voyager Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, GYRE or VYGR? Gyre Therapeutics has a beta of 1.86, suggesting that its stock price is 86% more volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. SummaryGyre Therapeutics beats Voyager Therapeutics on 11 of the 17 factors compared between the two stocks. Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VYGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VYGR vs. The Competition Export to ExcelMetricVoyager TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$204.13M$3.10B$5.75B$9.83BDividend YieldN/A2.28%6.66%4.49%P/E Ratio-1.9921.2382.4426.63Price / Sales4.79398.88530.80110.54Price / CashN/A43.5325.7028.92Price / Book0.848.1310.646.56Net Income-$65M-$53.35M$3.28B$266.04M7 Day Performance7.60%0.45%-0.08%-0.58%1 Month Performance24.32%9.94%10.36%6.24%1 Year Performance-41.12%11.73%49.00%22.21% Voyager Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VYGRVoyager Therapeutics4.1692 of 5 stars$3.68+2.8%$13.25+260.0%-45.4%$204.13M$42.58M-1.99100GYREGyre Therapeutics1.6835 of 5 stars$7.74-6.5%$18.00+132.6%-44.0%$745.44M$105.76M774.7740BGMBGM GroupN/A$7.51-2.2%N/A+7.6%$730.14M$26.85M0.00298Gap UpSANASana Biotechnology2.4473 of 5 stars$3.06+1.7%$8.00+161.4%-53.1%$727.70MN/A-2.89380Positive NewsNRIXNurix Therapeutics2.5862 of 5 stars$9.34-0.7%$28.87+209.1%-63.8%$714.03M$88.38M-3.58300News CoveragePositive NewsHigh Trading VolumeABUSArbutus Biopharma2.5678 of 5 stars$3.71+1.1%$5.50+48.2%-1.3%$711.21M$6.17M-12.7990News CoveragePositive NewsSNDLSNDL3.4726 of 5 stars$2.68-0.4%$4.00+49.3%+25.4%$704.24M$944.25M-9.932,516News CoverageAnalyst ForecastGap UpOCSOculis2.5087 of 5 stars$16.13-1.3%$35.75+121.6%+34.6%$704.24M$780K-6.042Short Interest ↑GHRSGH Research1.7165 of 5 stars$13.50-2.5%$32.00+137.0%+32.7%$702.41MN/A-18.2410News CoverageTBPHTheravance Biopharma3.6314 of 5 stars$13.88-0.6%$21.33+53.7%+67.8%$699.00M$64.38M57.83110News CoveragePositive NewsPROKProKidney3.2537 of 5 stars$2.36-5.6%$6.25+164.8%-4.2%$694.50M$80K-4.143News Coverage Related Companies and Tools Related Companies Gyre Therapeutics Alternatives BGM Group Alternatives Sana Biotechnology Alternatives Nurix Therapeutics Alternatives Arbutus Biopharma Alternatives SNDL Alternatives Oculis Alternatives GH Research Alternatives Theravance Biopharma Alternatives ProKidney Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VYGR) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VYGR Stock Alerts